Good MorningEquity markets resumed their downward movement on Thursday after a weaker-than-expected GDP reading. The first estimate for Q1 GDP came in at 1.6%, well below the consensus forecast. The weak data renewed fear of slowing growth and a possible recession, cutting more than 1.0% off the Dow Jones Industrial Average and S&P 500 before the open. However, the market began to recover by the end of the session and closed the day off of the low.
Where the market goes next will come down to data released today. The PCE price index is due and expected to be hot. A hot read will keep the FOMC's foot on the economic brake, increasing the odds of a recession. However, the FOMC's policy is sufficiently tight. It can act to stave off recession, given the inflation data cooperates. Because the economy is still growing, the S&P could still move higher.
The risk now is stagflation. The Fed can stave off a recession, but if it is forced to cut rates sooner than necessary to fight inflation to fight recession instead, inflation will accelerate and remain a problem. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Technology | | The semiconductor sector, usually a beacon of market strength, found itself in a storm last Friday. Shares of NVIDIA Corp. (NASDAQ: NVDA) closed the day down 10%, wiping out nearly $200 billion in market capitalization. This dramatic plunge sent shockwaves through the industry, leaving many leading ... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Consumer Discretionary | | After announcing the first quarter 2024 financial results, arguably the most critical quarter of the year as it sets the tone for any stock, shares of Hasbro Inc. (NASDAQ: HAS) jumped by as much as 12%.
With Mattel Inc. (NASDAQ: MAT) also rallying on earnings and flirting with new 52-week high pri... Read the Full Story |
|
Industrials | | The market’s reaction to Caterpillar’s (NYSE: CAT) Q1 results and guidance proves that the correction in price action is not over. The news isn’t bad, but tepid and weaker than expected, causing a sentiment reset. Analysts rate the stock at Hold and lifted their price targets stead... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Utilities | |
One standout player in the exchange-traded funds (ETFs) world has been making waves for its recent relative strength: the Utilities Select Sector SPDR Fund (NYSEARCA: XLU). It's been holding its ground well this year, clocking in gains of almost 5% so far. Lately, however, it's caught up with the ... Read the Full Story |
|
Consumer Discretionary | |
Markets were scared to wake up to the Federal Reserve (the Fed) pulling the rug. After pricing in the proposed interest rate cuts for 2024, which were set to be implemented by March, then May, and now September, according to the CME’s FedWatch tool, markets retraced on the thought of no more... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Technology | |
Anyone waiting for a pullback in Meta Platforms (NASDAQ: META) stock should cheer the Q1 results. The news underscores the company’s strengths yet resulted in a 15% correction in the share price. Analysts are adjusting their targets but continue seeing substantial upside, leading the market ... Read the Full Story |
|
Basic Materials | | After outperforming the Industrial Select Sector SPDR Fund (NYSEARCA: XLI) by more than 15% over the past five months, shares of Nucor Co. (NYSE: NUE) have now fallen behind the sector after reporting its first quarter 2024 earnings, arguably the most important earnings for the year as they set the ... Read the Full Story |
|
Construction | |
Simpson Manufacturing Co. (NYSE: SSD) sent its share price reeling as it reported its struggles during Q1 2024, but this is a great time to buy this construction stock. You don’t buy Simpson because of today’s results, or even next quarter’s or next year’s, but because of t... Read the Full Story |
|
Aerospace | |
Some stocks are undeniable pillars in their respective industries, and sometimes even for an entire economy. Shares of Boeing Co. (NYSE: BA) saw little change after it reported its first quarter 2024 earnings results, arguably the most important earnings report of the year as it set the tone for t... Read the Full Story |
|
Technology | | Texas Instruments (NASDAQ: TXN) dividend is unique among chipmakers for its yield, if nothing else. The stock yields over 3.15%, which is double or better than the rest of the field, and it is a safe and growing distribution.
The dividend alone may not be a reason to buy the stock but the opportun... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen that is in Phase 1 clinical trial for the treatment of relapsed/refractory (r/r) non-hodgkin lymphoma, as well as for lupus nephritis. It also develops NKX101, a CAR NK product candidate targeting cells that display NKG2D ligands, which is in Phase I clinical trial for the treatment of r/r acute myeloid leukemia or higher risk myelodysplastic syndromes, as well as for solid tumors. In addition, the company develops NKX070, targeting the CD70 tumor antigen to treat solid and liquid tumors; and NK+T cell therapy for use in the treatment of oncology, autoimmune disease, or infectious disease. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California. | | View Today's Stock Pick |
|
